What is Elutia, Inc. (ELUT) stock price today?

Elutia, Inc. (ELUT) is currently trading at $0.82, down 0.51% today.

What is ELUT P/E ratio?

Elutia, Inc.'s P/E ratio is 0.60. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ELUT return on equity (ROE)?

Elutia, Inc.'s return on equity (ROE) is 940.81%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Elutia, Inc.'s market cap?

Elutia, Inc. has a market capitalization of $36.39M.

NCM · Biotechnology

Elutia, Inc. (ELUT) Stock

$0.82 -0.51% NCM: ELUT Healthcare

Valuation

Metric	Value
Price	$0.82
Market Cap	$36.39M
P/E Ratio	0.60
P/B Ratio	2.16
P/S Ratio	2.84
EPS (TTM)	$-0.79
52-Week High	$1.39
52-Week Low	$0.50
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	940.81%
ROA	118.69%
ROCE	-104.16%
Gross Margin	-158.33%
Operating Margin	-150.00%
Net Margin	426.93%
Debt/Equity	0.69
Current Ratio	2.24

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$47.0M	$24.0M	$25.0M	$24.0M	$12.0M
Operating Profit	$-23.0M	$-35.0M	$-31.0M	$-36.0M	$-18.0M
Net Profit	$-25.0M	$-33.0M	$-38.0M	$-54.0M	$53.0M
EPS	$-2.38	$-2.38	$-2.07	$-1.86	$0.87
Op Margin	-48.6%	-147.6%	-123.4%	-146.3%	-149.8%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$67.0M	$69.0M	$43.0M	$36.0M	$62.0M
Total Liabilities	$54.0M	$74.0M	$82.0M	$82.0M	$35.0M
Cash	$30.0M	$17.0M	$19.0M	$13.0M	$36.0M
Borrowings	$23.0M	$25.0M	$24.0M	$24.0M	$11.0M

Latest News

Elutia to Present at Planet MicroCap Showcase 2026 on June 17th GlobeNewswire · Jun 11, 2026 Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · May 18, 2026 Elutia (ELUT) Q1 2026 Earnings Transcript Motley Fool · May 15, 2026 Elutia Inc. Q1 2026 Earnings Call Summary Moby · May 15, 2026 Elutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Revenue Shifts GuruFocus.com · May 15, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-15.0M	$-21.0M	$-22.0M	$-23.0M	$-45.0M
Investing Cash Flow	$-1.0M	$-1.0M	$14.0M	$-1.0M	$77.0M
Financing Cash Flow	$-3.0M	$-3.0M	$12.0M	$19.0M	$-1.0M
Net Cash Flow	$-9.0M	$-13.0M	$2.0M	$-6.0M	$23.0M
Free Cash Flow	$-16.0M	$-22.0M	$-22.0M	$-23.0M	$-47.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-1.05
FCF Yield	-132.10%
Quick Ratio	1.64
Interest Coverage	6.77
Return 1Y	-52.53%
Return 3Y	-60.91%
Return 5Y	-87.55%

Ownership

Insiders Held3.51%

Institutions Held45.56%

Institutions Float Held47.22%

Institutional Holder	Shares	Report Date
AIGH Capital Management LLC	3,595,250	2026-03-31
Nantahala Capital Management, LLC	3,184,947	2026-03-31
Knollwood Investment Advisory, LLC	2,556,724	2026-03-31
SilverArc Capital Management, LLC	2,498,020	2026-03-31
Vanguard Capital Management LLC	1,023,699	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ANVSAnnovis Bio, Inc.	$1.21	+3.42%	-0.67	$51.48M	0.00%
BCAB	$1.74	+0.00%	-0.12	$2.88M	0.00%
CALCCalciMedica, Inc.	$1.27	-2.31%	-0.21	$4.00M	0.00%
CELUCelularity Inc.	$1.56	+6.85%	-0.51	$45.16M	0.00%
LTRNLantern Pharma Inc.	$0.81	-2.08%	-0.51	$10.37M	0.00%

About Elutia, Inc.

Elutia, Inc. is led by CEO C. Randal Mills, employs 51 people, headquartered in US, publicly traded since 2020.

Elutia, Inc. (ELUT) stock trades at $0.82 with a market capitalization of $36.39M. The stock is valued at a price-to-earnings (P/E) ratio of 0.60, price-to-book of 2.16, price-to-sales of 2.84. Over the past 52 weeks the stock has ranged between $0.50 and $1.39, and currently trades 41.0% below its 52-week high.

On profitability, Elutia, Inc. generates a return on equity (ROE) of 940.81% — well above the market average, a sign of a high-quality business, return on capital employed of -104.16%, an operating margin of -150.00%, a net profit margin of 426.93%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides